Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | CASP1 | P29466 | 2/20 | 0.58 |
| ▸ | CASP7 | P55210 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | SRC | P12931 | 2/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.40 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15842332 | 0.81 | PGR (0.43) | GAAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL12040002 | 0.80 | CA12 (0.53) | GAAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL28642209 | 0.80 | MAOB (0.47) | KMT2AALDH1A1MEN1CA2AR | |
| SCHEMBL106506 | 0.80 | HSD17B3 (0.58) | GAAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL15842386 | 0.78 | HTT (0.39) | GAAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL383681 | 0.77 | HPGD (0.55) | GAAKDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL7544470 | 0.77 | HPGD (0.55) | GAAKDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL16085333 | 0.77 | SMN1; SMN2 (0.63) | GAAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL27935835 | 0.76 | MEN1 (0.44) | GAAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL1712282 | 0.76 | MAOB (0.57) | GAAKMT2AKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130203078-A1 | NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF | CANVAX BIOTECH SL (ES) | 2013-08-08 | — | — | US | claimed |
| EP-2598876-A1 | NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF | Canvax Biotech SL (ES) | 2013-06-05 | — | — | EP | claimed |
| WO-2012013204-A1 | NOVEL ULTRASENSITIVE CELL BASED SENSORS AND USES THEREOF | CANVAX BIOTECH SL (ES) | 2012-02-02 | — | — | WO | claimed |
| US-20060281897-A1 | Potentialization of the activation of high molecular weight prodrugs | DIATOS S.A. (FR) | 2006-12-14 | — | — | US | claimed |
| CN-122025633-A | Polymeric adhesive for electrochemical cells including labels | 通用汽车环球科技运作有限责任公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4619417-A1 | NANOCONJUGATES CONTAINING PDGFR-BETA LIGANDS AND USES THEREOF | Universitat Autònoma de Barcelona (ES) | 2025-09-24 | — | — | EP | disclosed |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | disclosed |
| EP-4493273-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | Politechnika Wroclawska (PL) | 2025-01-22 | — | — | EP | disclosed |
| CN-118369344-A | Anti-human CD45RC binding domain and uses thereof | 阿博莱斯制药公司 | 2024-07-19 | — | — | CN | disclosed |
| WO-2024105116-A1 | NANOCONJUGATES CONTAINING PDGFR-β LIGANDS AND USES THEREOF | UNIVERSITAT AUTÒNOMA DE BARCELONA (ES) | 2024-05-23 | — | — | WO | disclosed |
| WO-2023175356-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | POLITECHNIKA WROCLAWSKA (PL) | 2023-09-21 | — | — | WO | disclosed |
| US-20230204587-A1 | NOVEL DIAGNOSTIC MARKER FOR PROSTATE CANCER | URTESTE S.A. (PL) | 2023-06-29 | — | — | US | disclosed |
| WO-2000032044-A1 | A NEW SUPPORT FOR HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY AND OTHER USES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-1999038993-A1 | COMBINATORIAL QUINOLONE LIBRARY | PHARMACOPEIA, INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| EP-0904401-A4 | — | — | 1999-05-12 | — | — | EP | disclosed |
| EP-0904401-A1 | COMBINATORIAL HYDROXYPROPYLAMINE LIBRARY | PHARMACOPEIA, INC. (US) | 1999-03-31 | — | — | EP | disclosed |
| US-5856083-A | Lawn assay for compounds that affect enzyme activity or bind to target molecules | PHARMACOPEIA, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| US-5766963-A | IDENTIFYING BIOLOGICALLY ACTIVE MEMBERS BY SCREENING IN BIOASSAYS | PHARMACOPEIA, INC. (US) | 1998-06-16 | — | — | US | disclosed |
| WO-1997027315-A1 | COMBINATORIAL HYDROXYPROPYLAMINE LIBRARY | PHARMACOPEIA, INC. (US) | 1997-07-31 | — | — | WO | disclosed |
| WO-1997016569-A1 | LAWN ASSAY FOR COMPOUNDS THAT AFFECT ENZYME ACTIVITY OR BIND TO TARGET MOLECULES | PHARMACOPEIA, INC. (US) | 1997-05-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | F11, F2, F12 | GAA 932/4885KMT2A 2823/4885KDM4E 3069/4885 |
| US-20060281897-A1 | Potentialization of the activation of high molecular weight prodrugs | CD44, MMP12, FOLH1 | GAA 287/4885KMT2A 3864/4885KDM4E 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.